A new study conducted by IMARC' Group, one of the world's leading research and advisory firms, finds that driven by a large diabetes population, improving diagnosis and drug treatment rates, upgradation of the healthcare infrastructure and a very bright outlook for patented drugs; the market for diabetes drugs consisting of...

<A HREF="http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=55897">Read More</A>